Alphagan-P (soln)

Alphagan-P (soln)

Generic: Brimonidine 0.1% or 0.15%

Alphagan-P (soln)
DOSAGE 1 gtt TID. Clinically, BID is used most commonly
GENERIC brimonidine 0.1% or 0.15%
SIZE 5mL, 10mL, 15mL
INDICATIONS Reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.
MECHANISM OF ACTION alpha-2 agonist
MICROBIOLOGY Relatively selective alpha-2 adrenergic receptor agonist with a peak ocular hypotensive effect occurring at two hours post-dosing. Fluorophotometric studies in animals and humans suggest that brimonidine tartrate has a dual mechanism of action by reducing aqueous humor production and increasing uveoscleral outflow.
CONTRAINDICATIONS & WARNINGS History of hypersensitivity
PEDIATRIC USE Contraindicated under 2 years
PREGNANCY Pregnancy Category B: Teratogenicity studies have been performed in animals
NOTE The “P” stands for the preservative Purite